(Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (FY)Mar 31, 2022 | |
---|---|---|---|---|---|---|
Assets | ||||||
Current assets | ||||||
Cash, cash equivalents and short term investments | --340.1K | --427.11K | --558.44K | 47,937,900.00%479.38K | --479.38K | --1 |
-Cash and cash equivalents | --340.1K | --427.11K | --558.44K | 47,937,900.00%479.38K | --479.38K | --1 |
-Other receivables | ---- | --42.47K | --287 | ---- | ---- | ---- |
Total current assets | --345.49K | --427.11K | --558.44K | 64,360,400.00%643.61K | --643.61K | --1 |
Non current assets | ||||||
-Other intangible assets | ---- | ---- | --607.78K | --614.86K | --614.86K | ---- |
Regulatory assets | --5.4K | --0 | --0 | --164.23K | --164.23K | --0 |
Total assets | --5.4K | ---- | ---- | ---- | ---- | ---- |
Liabilities | ||||||
Current liabilities | ||||||
-accounts payable | --33.94K | ---- | ---- | ---- | ---- | ---- |
-Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 |
-Due to related parties current | ---- | --8.32K | --2.72K | ---- | ---- | ---- |
Current accrued expenses | --6.1K | ---- | ---- | ---- | ---- | ---- |
Current liabilities | --40.04K | --50.8K | --3.01K | --40.99K | --40.99K | --0 |
Non current liabilities | ||||||
Non current accrued expenses | --10.21K | ---- | ---- | ---- | ---- | ---- |
Total non current liabilities | --40.04K | --50.8K | --3.01K | --40.99K | --40.99K | --0 |
Shareholders'equity | ||||||
Share capital | --709.08K | --704.08K | --96.3K | 9,630,000.00%96.3K | --96.3K | --1 |
-common stock | --709.08K | --704.08K | --96.3K | 9,630,000.00%96.3K | --96.3K | --1 |
Gains losses not affecting retained earnings | --73.91K | ---- | ---- | ---- | ---- | ---- |
Total equity | --355.7K | --427.11K | --558.44K | 64,360,400.00%643.61K | --643.61K | --1 |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data